Intrinsic Value of S&P & Nasdaq Contact Us

Rennova Health, Inc. RNVAW OTC

Other OTC • Healthcare • Medical - Care Facilities • US • USD

SharesGrow Score
29/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Rennova Health, Inc. (RNVAW) is a Medical - Care Facilities company in the Healthcare sector, currently trading at $0.01. It has a SharesGrow Score of 27/100, indicating a weak investment profile with 0 out of 7 criteria passed.

Financials: revenue is $19M, +97.5%/yr average growth. Net income is $8M (loss), growing at -54.3%/yr. Net profit margin is -41.4% (negative). Gross margin is 59.5% (+123.2 pp trend).

Balance sheet: total debt is $12M with negative equity of -$37M — this means total liabilities exceed total assets. This is a warning sign that may indicate accumulated losses, aggressive share buybacks, heavy debt financing, or aggressive dividend payouts. Companies like McDonald's and Starbucks also carry negative equity due to buybacks and dividends, but investors should assess whether the business generates sufficient cash flow to service its debt and sustain payouts. Current ratio is 0.16 (tight liquidity). Debt-to-assets is 58.1%. Total assets: $20M.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 58/100 (Partial), Past 25/100 (Fail), Health 0/100 (Fail), Moat 50/100 (Partial), Future ?/100 (Fail), Income 10/100 (Fail).

RNVAW SharesGrow Score Overview

36/100
SharesGrow Score
Below average — proceed with caution
View full scorecard →
VALUE 0/100
Valuation — P/E, PEG, Forward PEG
GROWTH 58/100
Financials — average growth
PAST 25/100
strong — trend
HEALTH 0/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 50/100
Gross margin is + market cap
FUTURE 0/100
Analyst outlook — as buy
INCOME 10/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Stock Chart & Stats

Market Data
52-Week Range0.0069-0.00845
Volume2K
Avg Volume (30D)168.38K
Beta (1Y)0.00
Share Statistics
EPS (TTM)0.00
Shares Outstanding$32.83B
IPO Date2022-01-31
Employees63
CEOSeamus Lagan
Financial Highlights & Ratios
Revenue (TTM)$18.69M
Gross Profit$11.11M
EBITDA$1.45M
Net Income$-7.73M
Operating Income$1.37M
Total Cash$49.02K
Total Debt$11.78M
Net Debt$11.73M
Total Assets$20.25M
Price / Earnings (P/E)-42.3
Analyst Forecast
Company Info
CountryUS
ExchangeOther OTC
CurrencyUSD

Price Chart

RNVAW
Rennova Health, Inc.  ·  Other OTC
Healthcare • Medical - Care Facilities
0.01 52WK RANGE 0.01
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message